Association of cytotoxic T-lymphocyte antigen 4 +49A/G gene polymorphism with acute rejection risk in renal transplantation

Pediatr Transplant. 2017 Jun;21(4). doi: 10.1111/petr.12916. Epub 2017 Mar 23.

Abstract

The conclusions on the association between cytotoxic T-lymphocyte antigen 4 (CTLA4) +49A/G gene polymorphism and acute rejection risk in renal transplantation are still debated. This meta-analysis was performed to update the association between CTLA4 +49A/G and acute rejection risk in renal transplantation. The association investigations were identified from PubMed and Cochrane Library, and eligible studies were included and synthesized using meta-analysis method. Fourteen reports were included into this meta-analysis for the association of CTLA4 A/G gene polymorphism and acute rejection risk in renal transplantation, consisting of 962 acute rejection patients and 2084 non-acute rejection controls. The association between CTLA4 G allele/GG genotype and acute rejection risk in renal transplantation was found in this meta-analysis (G allele: OR=1.21, 95% CI: 1.03-1.44, P=.02; GG genotype: OR=1.37, 95% CI: 1.10-1.69, P=.004). However, the AA genotype was not associated with acute rejection risk in renal transplantation. In conclusion, CTLA4 G allele/GG genotype is associated with the acute rejection risk in renal transplantation.

Keywords: A/G gene polymorphism; acute rejection in renal transplantation; cytotoxic T-lymphocyte antigen 4 (CTLA4); meta-analysis.

Publication types

  • Meta-Analysis

MeSH terms

  • Biomarkers, Tumor / genetics*
  • CTLA-4 Antigen / genetics*
  • Genotype
  • Graft Rejection / genetics*
  • Humans
  • Kidney Transplantation*
  • Models, Statistical
  • Odds Ratio
  • Polymorphism, Single Nucleotide*
  • Risk Assessment
  • Risk Factors

Substances

  • Biomarkers, Tumor
  • CTLA-4 Antigen
  • CTLA4 protein, human